Mosqitter is turning its mosquito traps into an AI-powered surveillance network
Mosqitter, a Pennsylvania-based startup, is expanding its chemical-free mosquito traps into an AI-powered monitoring network. It aims to identify mosquito species, track population changes and provide earlier warnings of disease risks as shifting climate and travel patterns extend the range of disease-carrying mosquitoes.
The company says it has more than 5,000 devices operating across five continents, compared with just over 250 in 2022. Its computer-vision system analyses images, checks results against external datasets and has entomologists validate identifications; it also uses weather, wind and humidity data. Mosqitter plans to introduce its Febris Monitoring System next month, while the WHO reported global dengue cases rose from 6.5 million in 2023 to a record 14.6 million in 2024.
- Mosqitter wants its traps to monitor mosquito populations and disease risks.
- Its devices now operate across five continents.
- Dengue cases reached 14.6 million globally in 2024.
New here? Start with this
Mosquitoes are more than a nuisance: some species spread illnesses such as dengue, and different species can carry different diseases. Their ranges and numbers can change with weather, climate and human travel, making it useful to know where they are appearing.
Mosqitter is a Pennsylvania-based company that makes traps designed to catch mosquitoes without chemicals. Its monitoring system uses images and environmental data to help identify species and track changes in local populations, with specialists checking the identifications.
This information could help public-health teams spot changes that may signal a growing disease risk. It does not by itself show that an outbreak will happen, but it may add to the evidence used to decide where to investigate or prepare.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
A wider network of traps could give public health teams earlier, more local evidence about mosquito species and changing populations, helping them target prevention and prepare for outbreaks. Combining image analysis with expert validation and weather data may make monitoring more timely as climate and travel patterns shift disease risks.
The case against
Building a large monitoring network raises reasonable questions about how reliable its identifications and risk forecasts are, and whether public agencies should rely on a startup’s system when making health decisions. Even if the traps are chemical-free, expanding surveillance could also bring privacy, data-governance and accountability concerns that deserve clear answers.